This study compared two methods for examining the bladder: standard white light cystoscopy and fluorescence cystoscopy using 5-aminolevulinic acid. Researchers gave the contrast agent to 63 patients and performed both types of cystoscopy. In 21 patients, fluorescence revealed more abnormal areas than white light. Histology confirmed 11 of these findings. No side effects were reported. The authors suggest that fluorescence cystoscopy may be more sensitive for detecting early-stage bladder lesions. The method appears safe and could improve diagnostic accuracy in clinical practice.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Diagnosing bladder conditions remains a challenge in clinical practice. Traditional white light cystoscopy often fails to detect subtle abnormalities. Prior research has shown that some lesions appear visually similar to healthy tissue under standard lighting. This gap motivated the search for improved visualization methods. Fluorescence techniques have emerged as a promising alternative. These methods rely on substances that emit light when exposed to specific wavelengths. No prior work had resolved how fluorescence compares to standard cystoscopy in real-world settings. This uncertainty drove the need for direct comparison. The goal was to assess whether fluorescence could improve detection rates.
Purpose Of The Study:
The aim was to evaluate fluorescence cystoscopy's effectiveness compared to white light cystoscopy. A specific problem was the limited sensitivity of standard methods for early cancer detection. The motivation was to reduce missed diagnoses and improve patient outcomes. Researchers focused on 5-aminolevulinic acid as a potential contrast agent. This compound accumulates in abnormal cells and fluoresces under blue light. The study aimed to determine if this method could reveal more lesions. It also sought to confirm safety and feasibility in clinical use. The ultimate goal was to establish fluorescence as a reliable diagnostic tool.
Fluorescence cystoscopy detected more lesions in 21 out of 63 patients, with 11 confirmed by histology.
It accumulates in abnormal cells and fluoresces under blue light, helping identify lesions not visible in white light.
Blue light excites 5-aminolevulinic acid to emit fluorescence, making abnormal tissue more visible during cystoscopy.
Histological analysis confirmed 11 cases where fluorescence detected pathology not seen in white light.
Main Methods:
The study involved 63 participants undergoing cystoscopic evaluation. Each patient received 1 g of 5-aminolevulinic acid intravesically. Cystoscopy was performed first under white light, then under blue light. Findings from both methods were compared for each case. Lesions identified in one condition but not the other were recorded. Histological analysis confirmed the presence of pathology in ambiguous cases. Researchers documented any adverse effects of the contrast agent. The approach focused on direct comparison and validation through histology.
Main Results:
In 39 cases, both white and blue light cystoscopy showed identical findings. In 21 cases, blue light revealed additional pathological spots. Of these, 10 had lesions visible only under blue light. Histology confirmed 11 cases where blue light detected pathology not seen in white light. No differences were observed in the remaining 39 patients. The contrast agent did not cause any side effects. Lesion detection rates were higher with fluorescence. These results suggest improved sensitivity for abnormal tissue identification.
Conclusions:
The study supports the use of fluorescence cystoscopy for bladder evaluation. The authors propose that blue light reveals more lesions than white light. They suggest this method may improve early cancer detection. The findings align with histological confirmation in 11 cases. The absence of side effects supports clinical safety. The researchers propose that fluorescence could enhance diagnostic accuracy. They suggest this technique may reduce missed diagnoses. The study highlights the potential of fluorescence in urological practice.
Intravesical administration of 5-aminolevulinic acid had no reported side effects in the study.
The authors suggest fluorescence cystoscopy may improve early detection and reduce missed diagnoses.